Loading…
Held by 3 funds across 2 fund houses in our coverage.
Coverage: 23 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Sun Pharma Advanced Research Company is held by 3 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹5 Cr. Among all holding funds, the manager with the highest conviction is (Motilal Oswal MF), which allocates a significant 0.20% of its entire portfolio to Sun Pharma Advanced Research Company.
In terms of category distribution, Equity (Diversified) funds hold the largest exposure by market value, representing 2 positions. Across different fund houses, Motilal Oswal MF manages the largest aggregate stake, holding a combined value of ₹5 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
| # | MoM | Rank | ||||
|---|---|---|---|---|---|---|
| 1 | Motilal Oswal Nifty Microcap 250 Index FundMotilal Oswal MFEquity (Diversified)₹4.88 Cr | 0.20% | — | ₹4.88 Cr | 2.45 L | #186 of 229 |
| 2 | Motilal Oswal S&P BSE Healthcare ETFMotilal Oswal MFEquity (Diversified)₹5.16 L | 0.12% | — | ₹5.16 L | 2.6K | #75 of 125 |
| 3 | IB18-Groww Nifty Total Market Index FundGroww MFIndex Fund₹3.34 L | 0.01% | — | ₹3.34 L | 1.7K | #682 of 728 |
Portfolios as on: Motilal Oswal MF Aug 2026 · Groww MF Aug 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).